Reasonable Hypothesis SOP [1] | 104 of 2015 |
Balance of Probabilities SOP [2] | 105 of 2015 |
SOP Bulletin 185 [3]
Pleural (ICD-9 163; ICD-10 C45.0)
Pericardium (ICD-9 164.1; ICD-10 C45.2)
Peritoneum (ICD-9 158.8; ICD-10 C45.1)
This is a primary malignant neoplasm of the mesothelial cells of the body. These cells line closed potential spaces of the body including the pleura, pericardium, peritoneum and the tunica vaginalis of the testis.
To confirm the diagnosis there needs to be evidence on histology of the neoplasm.
The relevant medical specialist is an oncologist.
Soft tissue sarcoma*
Hodgkin’s lymphoma*
NonHodgkin’s lymphoma*
Carcinoid tumour#
* another SOP applies - the SOP has the same name unless otherwise specified
# non-SOP condition
The assessment of the clinical onset begins with the confirmed diagnosis on histopathology, then goes back in time to the first confirmed imaging of the neoplasia, and then further back if possible, to the onset of reliable, contiguous clinical symptoms and signs which are pathognomonic of the neoplasm. Clinical onset is typically a number of decades after relevant asbestos exposure.
For an aggravation to be relevant, there must be a clinical worsening out of keeping with the natural history of the underlying pathology. Mesotheioloma is usually rapidly fatal once diagnosed and unresponsive or poorly responsive to treatment. Inablity to obtain appropriate clincial management is unlikely to be relevant.
Place holder node for Rulebase for mesothelioma
Mesothelioma - Asbestosis Factor
Last reviewed for CCPS 15 October 2008.
Preliminary questions [40284]
31638 [5] there is some evidence that asbestosis may be a factor in the development of the condition under consideration.
31639 [5] the veteran has had asbestosis at some time.
31641 [6] the veteran had asbestosis at the time of the clinical onset of the condition under consideration. [7]
40287 — the veteran has established the causal connection between asbestosis and VEA service for the clinical onset of mesothelioma.
40288 — the veteran has established the causal connection between asbestosis and operational service for the clinical onset of mesothelioma.
or
40289 — the veteran has established the causal connection between asbestosis and eligible service for the clinical onset of mesothelioma.
Clinical onset and operational service [40288]
31648 — the asbestosis is causally related to operational service. [8] [9]
Clinical onset and eligible service [40289]
31649 — the asbestosis is causally related to eligible service. [10] [9]
Mesothelioma - Inability to obtain appropriate clinical management for mesothelioma Factor
Last reviewed for CCPS 15 October 2008.
Investigative Documents
Medical Report - Inability to Obtain Appropriate Clinical Management - [GQACM] Preliminary questions [32591] 11109 — the condition under consideration has been accepted on the basis of inability to obtain appropriate clinical management for the condition under consideration.
7334 [12] the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service. the condition under consideration permanently worsened. the veteran was unable to obtain appropriate clinical management for the condition under consideration at some time.
7379 [15] the inability to obtain appropriate clinical management for the condition under consideration contributed to the clinical worsening of the condition under consideration. 11234 — the veteran has established the causal connection between the inability to obtain appropriate clinical management for the condition under consideration and VEA service for the clinical worsening of the condition under consideration. 11235 — the veteran has established the causal connection between the inability to obtain appropriate clinical management for the condition under consideration and operational service for the clinical worsening of the condition under consideration. or 11236 — the veteran has established the causal connection between the inability to obtain appropriate clinical management for the condition under consideration and eligible service for the clinical worsening of the condition under consideration. Clinical worsening and operational service [11235] or 7390 — the identified illness or injury which prevented the veteran from obtaining appropriate clinical management for the condition under consideration is causally related to operational service. [20] [21] Clinical worsening and eligible service [11236] or 7391 — the identified illness or injury which prevented the veteran from obtaining appropriate clinical management for the condition under consideration is causally related to eligible service. [20] [21]
Mesothelioma - Inhaling asbestos fibres Factor
Last reviewed for CCPS 15 October 2008.
Investigative Documents
Claimant Report - Respirable Asbestos Fibres [CR9017] Preliminary questions [1688] 1689 — the veteran has established the causal connection between inhaling asbestos fibres and VEA service for the clinical onset of mesothelioma. 1690 — the veteran has established the causal connection between inhaling asbestos fibres and operational service for the clinical onset of mesothelioma. or 1691 — the veteran has established the causal connection between inhaling asbestos fibres and eligible service for the clinical onset of mesothelioma. Clinical onset and operational service [1690] Clinical onset and eligible service [1691] or
Mesothelioma - Inhaling erionite fibres Factor
Last reviewed for CCPS 15 October 2008.
Investigative Documents
Claimant Report - Inhaling Erionite Fibres [CR9303] Preliminary questions [40286]
40292 — the veteran has established the causal connection between inhaling erionite fibres and VEA service for the clinical onset of mesothelioma.
40293 — the veteran has established the causal connection between inhaling erionite fibres and operational service for the clinical onset of mesothelioma.
or
40294 — the veteran has established the causal connection between inhaling erionite fibres and eligible service for the clinical onset of mesothelioma.
Clinical onset and operational service [40293]
40295 [42] the veteran inhaled erionite fibres on more days than not for at least five years before the clinical onset of the condition under consideration where the first such inhalation occurred at least 10 years before that clinical onset. operational service made a material contribution to the veteran's inhalation of erionite fibres on more days than not for at least five years before the clinical onset of the condition under consideration, where the first such inhalation occurred at least 10 years before that clinical onset. Clinical onset and eligible service [40294]
Mesothelioma - Intravascular injection of thorium dioxide (Thorotrast) Factor
Last reviewed for CCPS 15 October 2008.
Preliminary questions [40285]
40299 [47] there is some evidence that an intravascular injection of thorium dioxide (Thorotrast) may be a factor in the development of the condition under consideration.
40300 [47] the veteran has had an intravascular injection of thorium dioxide (Thorotrast) at some time.
40301 [48] the veteran had an intravascular injection of thorium dioxide (Thorotrast) for treatment of an illness or injury which is identifiable. 40302 — the veteran has established the causal connection between an intravascular injection of thorium dioxide (Thorotrast) and VEA service for the clinical onset of mesothelioma. 40304 — the veteran has established the causal connection between an intravascular injection of thorium dioxide (Thorotrast) and eligible service for the clinical onset of mesothelioma. or 40303 — the veteran has established the causal connection between an intravascular injection of thorium dioxide (Thorotrast) and operational service for the clinical onset of mesothelioma. Clinical onset and operational service [40303] 40307 — the identified illness or injury, for which the veteran had the intravascular injection of thorium dioxide (Thorotrast), is causally related to operational service. [50] [51] Clinical onset and eligible service [40304]
40308 — the identified illness or injury, for which the veteran had the intravascular injection of thorium dioxide (Thorotrast), is causally related to eligible service. [54] [51]
Links
[1] http://www.rma.gov.au/SOP/15/104.pdf
[2] http://www.rma.gov.au/SOP/15/105.pdf
[3] https://clik.dva.gov.au/system/files/media/Bull185.pdf
[4] https://clik.dva.gov.au/user/login?destination=comment/reply/63846%23comment-form
[5] https://clik.dva.gov.au/ccpsb004rc-10
[6] clikpopup://CCPS/Had asbestosis at onset of mesothelioma
[7] clikpopup://CCPS/reject31641No
[8] clikpopup://CCPS/reject31648No
[9] clikpopup://CCPS/reject31648,31649No
[10] clikpopup://CCPS/reject31649No
[11] https://clik.dva.gov.au/ccpsother-31
[12] https://clik.dva.gov.au/node/71320
[13] clikpopup://CCPS/Reject/OnsetAfterService
[14] clikpopup://CCPS/Reject/NoPermanentWorsening
[15] clikpopup://CCPS/Mesothelioma/ACM - contributed to worsening
[16] clikpopup://CCPS/ACM/NoContribution
[17] clikpopup://CCPS/ACM/NotOpService
[18] clikpopup://CCPS/ACM/NotOperDuties
[19] clikpopup://CCPS/rejectwilful
[20] clikpopup://CCPS/ACM/NoIllness
[21] clikpopup://CCPS/reject7390,7391No
[22] clikpopup://CCPS/Mesothelioma/ACM - onset prior to operational service
[23] clikpopup://CCPS/ACM/OnsetFailOper
[24] clikpopup://CCPS/ACM/NotEligService
[25] clikpopup://CCPS/ACM/NotEligDuties
[26] clikpopup://CCPS/Mesothelioma/ACM - onset prior to eligible service
[27] clikpopup://CCPS/ACM/OnsetFailElig
[28] https://clik.dva.gov.au/ccpsclaimant-135
[29] https://clik.dva.gov.au/reasons-decision-198
[30] clikpopup://CCPS/reject1693No
[31] clikpopup://CCPS/reject1692No
[32] clikpopup://CCPS/reject1695No
[33] clikpopup://CCPS/reject40310No
[34] clikpopup://CCPS/Inhaled asbestos in enclosed space for first time 15 years before onset of mesothelioma on El service
[35] clikpopup://CCPS/reject1694No
[36] clikpopup://CCPS/reject4727No
[37] clikpopup://CCPS/reject40311No
[38] clikpopup://CCPS/reject40312No
[39] clikpopup://CCPS/reject40313No
[40] clikpopup://CCPS/reject40314No
[41] https://clik.dva.gov.au/ccpsclaimant-151
[42] clikpopup://CCPS/Inhaled erionite as specified in RH SoP before onset of mesothelioma
[43] clikpopup://CCPS/reject40295No
[44] clikpopup://CCPS/reject40297No
[45] clikpopup://CCPS/reject40296No
[46] clikpopup://CCPS/reject40298No
[47] https://clik.dva.gov.au/ccpsb044rc
[48] clikpopup://CCPS/Intravascular injection of thorotrast for identifiable illness or injury
[49] clikpopup://CCPS/reject40301No
[50] clikpopup://CCPS/reject40305No
[51] clikpopup://CCPS/reject40307,40308No
[52] clikpopup://CCPS/Intravascular injection of thorotrast for identified illness 15 years before onset of mesothelioma
[53] clikpopup://CCPS/reject40306No
[54] clikpopup://CCPS/reject40308No